Chicago, IL, United States of America

Maurizio F Facheris

USPTO Granted Patents = 1 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Maurizio F Facheris: Innovator in Pharmaceutical Formulations

Introduction

Maurizio F Facheris is a notable inventor based in Chicago, IL (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of Parkinson's disease. His innovative work has led to the development of unique formulations that enhance the efficacy of treatment options available for patients.

Latest Patents

Facheris holds a patent for "Pharmaceutical formulations for subcutaneous administration." This patent focuses on compositions of levodopa 4'-monophosphate and carbidopa 4′-monophosphate, which are formulated in a weight by weight ratio of about 20:1. The methods described in this patent aim to treat Parkinson's disease and associated conditions through subcutaneous administration of these compositions. He has 1 patent to his name.

Career Highlights

Throughout his career, Maurizio F Facheris has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with AbbVie Inc. and Abb Vie Deutschland GmbH & Co. KG. His experience in these organizations has allowed him to contribute to significant advancements in drug formulations and patient care.

Collaborations

Facheris has collaborated with various professionals in his field, including Ehab Moussa and Matthew Rosebraugh. These collaborations have fostered an environment of innovation and have led to the development of effective pharmaceutical solutions.

Conclusion

Maurizio F Facheris is a distinguished inventor whose work in pharmaceutical formulations has the potential to improve the lives of those suffering from Parkinson's disease. His contributions to the field exemplify the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…